Skip to main content
SpringerLink
Log in

Pelvic Radiation in Men

  • Chapter
  • First Online:
Cancer and Sexual Health

Part of the book series: Current Clinical Urology ((CCU))

  • 1555 Accesses

Abstract

Despite the decrease in overall cancer incidence and mortality rates in developed countries since the early 1990s, cancer remains a major public health problem. Among men, the most common cancer affects the prostate and occurs more often in the older population [1]. Patient’s quality of life, including sexual functioning, has, in recent years, come to play a more significant role in decision making about treatment type. In the 1980s and 1990s, penile prostheses and penile injections created a market for male sexual ­dysfunction. With the introduction of sildenafil (Viagra®) in 1998, media attention toward ­erectile dysfunction (ED) has made sexual ­problems more normative and has increased acceptance of help-seeking [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  2. Addis ME, Mahalik JR. Men, masculinity, and the context of help-seeking. Am Psychol. 2003;58:5–14.

    Article  PubMed  Google Scholar 

  3. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF). A multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  PubMed  CAS  Google Scholar 

  4. Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F, editors. 2nd International consultation on sexual dysfunctions. Sexual medicine. Plymouth: Health Publications; 2004.

    Google Scholar 

  5. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26.

    Article  PubMed  CAS  Google Scholar 

  6. Incrocci L, Slob AK, Levendag PC. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys. 2002;52:681–93.

    Article  PubMed  Google Scholar 

  7. Incrocci L, Slob AK. Incidence, etiology, and therapy for erectile dysfunction after external beam radiotherapy for prostate cancer. Urology. 2002;60:1–7.

    Article  PubMed  Google Scholar 

  8. Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: what do we know? Critl Rev Oncol Hematol. 2006;57:165–73.

    Article  Google Scholar 

  9. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 1998;40:129–33.

    Article  PubMed  CAS  Google Scholar 

  10. DiBiase SJ, Wallner K, Tralins K, Sutlief S. Brachyther­apy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys. 2000;46:1301–7.

    Article  PubMed  CAS  Google Scholar 

  11. Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2000;48:1069–74.

    Article  PubMed  CAS  Google Scholar 

  12. Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2001;50:597–604.

    Article  PubMed  CAS  Google Scholar 

  13. Merrick GS, Butler WM, Wallner KE, et al. The importance of radiation doses to the penile bulb versus crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys. 2002;54:1055–62.

    Article  PubMed  Google Scholar 

  14. Merrick GS, Butler WM, Wallner KE, et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;62:437–47.

    Article  PubMed  Google Scholar 

  15. Fisch BM, Pickett B, Weinberg V, Roach M. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology. 2001;57:955–9.

    Article  PubMed  CAS  Google Scholar 

  16. Kiteley RA, Lee WR, deGuzman AF, et al. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy. 2002;1:90–4.

    Article  PubMed  Google Scholar 

  17. Selek U, Cheung R, Lii M, et al. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys. 2004;59:1039–46.

    Article  PubMed  Google Scholar 

  18. Roach M, Winter K, Michalski JM, et al. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys. 2004;60:1351–6.

    Article  PubMed  Google Scholar 

  19. Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004;60:1357–63.

    Article  PubMed  Google Scholar 

  20. Wright JL, Newhouse JH, Laguna JL, Vecchio D, Ennis RD. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;59:426–35.

    Article  PubMed  Google Scholar 

  21. Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan W, Morris WJ. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important? Int J Radiat Oncol Biol Phys. 2005;63:155–63.

    Article  PubMed  Google Scholar 

  22. Mangar SA, Sydes MR, Tucker HL, et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol. 2006;80:355–62.

    Article  PubMed  Google Scholar 

  23. Brown MW, Brooks JP, Albert PS, Poggi MM. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma. Prostate Cancer Prostatic Dis. 2007;10:189–93.

    Article  PubMed  CAS  Google Scholar 

  24. van der Wielen GJ, Hoogeman MS, Dohle GR, van Putten WLJ, Incrocci L. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial. Int J Radiat Oncol Biol Phys. 2008;71:795–800.

    Article  PubMed  Google Scholar 

  25. Solan AN, Cesaretti JA, Stone NN, Stock RG. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:1468–74.

    Article  PubMed  Google Scholar 

  26. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol. 2007;84:107–13.

    Article  PubMed  Google Scholar 

  27. Incrocci L. Brachytherapy of prostate cancer and sexual dysfunction. Urooncology. 2002;2:107–12.

    Article  CAS  Google Scholar 

  28. Pilepich MV, Krall JM, Al-Sarraf M, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995;45:616–23.

    Article  PubMed  CAS  Google Scholar 

  29. Beckendorf V, Hay M, Rozan R, Lagrange JL, N’Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer. Br J Urol. 1996;77:118–23.

    PubMed  CAS  Google Scholar 

  30. Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol. 1997;15:223–9.

    PubMed  CAS  Google Scholar 

  31. Borghede G, Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications: a prospective study. Radiother Oncol. 1997;43:139–46.

    Article  PubMed  CAS  Google Scholar 

  32. Turner SL, Adams K, Bull CA, Berry MP. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology. 1999;54:124–9.

    Article  PubMed  CAS  Google Scholar 

  33. van der Wielen GJ, van Putten WLJ, Incrocci L. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial. Int J Radiat Oncol Biol Phys. 2007;68:479–84.

    Article  PubMed  Google Scholar 

  34. Pinkawa M, Gagel B, Piroth MD, et al. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol. 2009;55:227–36.

    Article  PubMed  Google Scholar 

  35. Martinez A, Gonzalez J, Stromberg J, et al. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial. Int J Radiat Oncol Biol Phys. 1995;33:1019–27.

    Article  PubMed  CAS  Google Scholar 

  36. Arterbery VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A. Quality of life after permanent prostate implant. Surg Oncol. 1997;13:461–4.

    Article  CAS  Google Scholar 

  37. Koutrouvelis PG. Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: a preliminary report. J Urol. 1998;159:142–5.

    Article  PubMed  CAS  Google Scholar 

  38. Joly F, Brune D, Couette JE, et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol. 1998;9:751–7.

    Article  PubMed  CAS  Google Scholar 

  39. Sharkey J, Chovnick SD, Behar RJ, et al. Outpatient ultrasound-guided palladium-103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients. Urology. 1998;51:796–803.

    Article  PubMed  CAS  Google Scholar 

  40. Kestin LL, Martinez AA, Stromberg JS, et al. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol. 2000;18:2869–80.

    PubMed  CAS  Google Scholar 

  41. Sánchez-Ortiz RF, Broderick GA, Rovner ES, Wein AJ, Whittington R, Malkowicz SB. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000;12:18–24.

    Article  Google Scholar 

  42. Sharkey J, Chovnick SD, Behar RJ, et al. Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided Palladium-103 brachytherapy. J Endourol. 2000;14:343–50.

    Article  PubMed  CAS  Google Scholar 

  43. Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;47:1261–6.

    Article  PubMed  CAS  Google Scholar 

  44. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001;50:1235–42.

    Article  PubMed  CAS  Google Scholar 

  45. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol. 2001;165:436–9.

    Article  PubMed  CAS  Google Scholar 

  46. Little FA, Howard GCW. Sexual function following radical radiotherapy for bladder cancer. Radiother Oncol. 1988;49:157–61.

    Article  Google Scholar 

  47. Fokdal L, Hoyer M, Meldgaard P, et al. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2004;17:139–45.

    Article  Google Scholar 

  48. Mansson A, Caruso A, Capovilla E, et al. Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men. BJU Int. 2000;85:26–31.

    Article  PubMed  CAS  Google Scholar 

  49. Bjerre B, Johansen C, Steven K. Sexological problems after cystectomy: bladder substitution compared with ileal conduit diversion. Scand J Urol Nephrol. 1998;32:187–93.

    Article  PubMed  CAS  Google Scholar 

  50. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 2004;5:240–7.

    Article  PubMed  Google Scholar 

  51. Windhal T, Skeppner E, Andersson SO, et al. Sexual function and satisfaction in men after laser treatment for penile carcinoma. J Urol. 2004;17:2648–51.

    Google Scholar 

  52. Opjordsmoen S, Wahere H, Aass N, et al. Sexuality in patients treated for penile cancer: patients’ experience and doctors’ judgment. Br J Urol. 1994;73:554–60.

    Article  PubMed  CAS  Google Scholar 

  53. Che M, Tamboli P, Ro J, et al. Bilateral testicular germ cell tumours: twenty-year experience at M.D. Anderson. Cancer. 2002;95:1228–33.

    Article  PubMed  Google Scholar 

  54. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170:5–11.

    Article  PubMed  Google Scholar 

  55. van Basten JP, Koops Schraffoedt H, Sleijfer DT, et al. Current concepts about testicular cancer. Eur J Surg Oncol. 1997;23:354–66.

    Article  PubMed  Google Scholar 

  56. Schover LR, Gonzales M, von Eschenbach AC. Sexual and marital relationships after radiotherapy for seminoma. Urology. 1986;27:117–23.

    Article  PubMed  CAS  Google Scholar 

  57. Jonker-Pool G, van Basten JP, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer. Cancer. 1997;80:454–64.

    Article  PubMed  CAS  Google Scholar 

  58. Tinkler SD, Howard GCW, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumors of the testis. Radiother Oncol. 1992;25:207–12.

    Article  PubMed  CAS  Google Scholar 

  59. Caffo O, Amichetti M. Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis. BJU Int. 1999;83:462–8.

    Article  PubMed  CAS  Google Scholar 

  60. Incrocci L, Hop WCJ, Wijnmaalen A, Slob AK. Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for stage I-II testicular seminoma. Int J Radiat Oncol Biol Phys. 2002;53:1165–73.

    Article  PubMed  Google Scholar 

  61. Arai Y, Kawakita M, Okada Y, et al. Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol. 1997;15:1444–8.

    PubMed  CAS  Google Scholar 

  62. Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review. J Psychol Res. 2001;51:735–43.

    CAS  Google Scholar 

  63. van Basten JP, Jonker-Pool G, van Driel MF, et al. Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor. J Urol. 1997;158:1411–6.

    Article  PubMed  Google Scholar 

  64. Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD. Long-term effects of testicular cancer on sexual functioning in married couples. Cancer. 1989;64:1560–7.

    Article  PubMed  CAS  Google Scholar 

  65. Incrocci L, Bosch JLHR, Slob AK. Testicular prostheses: body image and sexual functioning. BJU Int. 1999;84:1043–5.

    Article  PubMed  CAS  Google Scholar 

  66. Adshead J, Khoubehi B, Wood J, et al. Testicular implants and patient satisfaction: a questionnaire-based study of men after orchidectomy for testicular cancer. BJU Int. 2001;88:559–62.

    Article  PubMed  CAS  Google Scholar 

  67. Lynch MJ, Pryor JP. Testicular prostheses: the patient’s perception. Br J Urol. 1992;70:420–2.

    Article  PubMed  CAS  Google Scholar 

  68. Bonnel C, Parc YR, Pocard M, et al. Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum. 2002;45:934–9.

    Article  PubMed  Google Scholar 

  69. Marijnen CAM, van de Velde CJH, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer. Report of a multicenter randomized trial. J Clin Oncol. 2005;23:1847–58.

    Article  PubMed  Google Scholar 

  70. Nesbakken A, Nygaard K, Bull-Njaa T, et al. Bladder and sexual dysfunction after mesorectal excision for rectal cancer. Br J Surg. 2000;87:206–10.

    Article  PubMed  CAS  Google Scholar 

  71. Pocard M, Zinzindohoue F, Haab F, et al. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery. 2002;131:368–72.

    Article  PubMed  Google Scholar 

  72. Maas CP, Moriya Y, Steup WH, et al. Radical and nerve-preserving surgery for rectal cancer in the Netherlands: a prospective study on morbidity and functional outcome. Br J Surg. 1998;85:92–7.

    Article  PubMed  CAS  Google Scholar 

  73. Arai Y, Aoki Y, Okubo K, et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol. 2000;164:1206–11.

    Article  PubMed  CAS  Google Scholar 

  74. Pierce LJ, Whittington R, Hanno PM, English W, Wein AJ, Goodman RL. Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report. Int J Radiat Oncol Biol Phys. 1991;21:1311–4.

    Article  PubMed  CAS  Google Scholar 

  75. Dubocq FM, Bianco Jr FJ, Maralani SJ, Forman JD, Dhabuwala CB. Outcome analysis of penile implant surgery after external beam radiation for prostate cancer. J Urol. 1997;158:1787–90.

    Article  PubMed  CAS  Google Scholar 

  76. Zelefsky MJ, McKee AB, Lee H, Leibel SA. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology. 1999;53:775–8.

    Article  PubMed  CAS  Google Scholar 

  77. Kedia S, Zippe CD, Agarwal A, Nelson DR, Lakin MM. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology. 1999;54:308–12.

    Article  PubMed  CAS  Google Scholar 

  78. Valicenti RK, Choi E, Chen C, et al. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology. 2001;57:769–73.

    Article  PubMed  CAS  Google Scholar 

  79. Weber DC, Bieri S, Kurtz JM, Miralbell R. Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer. J Clin Oncol. 1999;17:3444–9.

    PubMed  CAS  Google Scholar 

  80. Ohebshalom M, Parker M, Guhring P, Mulhall JP. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations. J Urol. 2005;174:258–62.

    Article  PubMed  CAS  Google Scholar 

  81. Incrocci L, Koper PCM, Hop WCJ, Slob AK. Sildenafil citrate (Viagra) and erectile dysfunction following external-beam radiotherapy for prostate cancer. A randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys. 2001;51:1190–5.

    Article  PubMed  CAS  Google Scholar 

  82. Incrocci L, Hop WCJ, Slob AK. Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy of prostate cancer. Urology. 2003;62:116–20.

    Article  PubMed  Google Scholar 

  83. Incrocci L, Slagter C, Slob AK, Hop WCJ. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis®) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys. 2006;66:439–44.

    Article  PubMed  CAS  Google Scholar 

  84. Incrocci L, Slob AK, Hop WC. Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial. Urology. 2007;70:1190–3.

    Article  PubMed  Google Scholar 

  85. Sethi A, Mohideen N, Leybovich L, Mulhall J. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;55:970–8.

    Article  PubMed  Google Scholar 

  86. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med. 2007;4:538–43.

    Article  PubMed  Google Scholar 

  87. Schiff JD, Bar-Chama N, Cesaretti J, Stock R. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int. 2006;98:1255–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands

    Luca Incrocci

Authors
  1. Luca Incrocci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Incrocci .

Editor information

Editors and Affiliations

  1. Sexual Medicine Program, Memorial Sloan-Kettering Cancer Center, East 68th Street 353, New York, 10021, New York, USA

    John P. Mulhall

  2. Daniel den Hoed Cancer Center, Dept. Radiation Oncology, Erasmus Medical Center, Groene Hilledijk 301, Rotterdam, 3075 EA, Netherlands

    Luca Incrocci

  3. Alvarado Hospital, Alvarado Road 6719, San Diego, 92120, California, USA

    Irwin Goldstein

  4. New England Research Institutes, Galen Street 9, Watertown, 02472, Massachusetts, USA

    Ray Rosen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Incrocci, L. (2011). Pelvic Radiation in Men. In: Mulhall, J., Incrocci, L., Goldstein, I., Rosen, R. (eds) Cancer and Sexual Health. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60761-916-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-916-1_31

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-915-4

  • Online ISBN: 978-1-60761-916-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation